Georg M Schmölzer1, Manoj Kumar2, Khalid Aziz2, Gerhard Pichler1, Megan O'Reilly2, Gianluca Lista3, Po-Yin Cheung2. 1. Centre for the Studies of Asphyxia and Resuscitation, Neonatal Research Unit, Royal Alexandra Hospital, Edmonton, Alberta, Canada Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada Department of Paediatrics, Medical University Graz, Graz, Austria. 2. Centre for the Studies of Asphyxia and Resuscitation, Neonatal Research Unit, Royal Alexandra Hospital, Edmonton, Alberta, Canada Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. 3. Division of Neonatology, 'V Buzzi' Children's Hospital-ICP, Milan, Italy.
Abstract
CONTEXT: Sustained inflation (SI) has been advocated as an alternative to intermittent positive pressure ventilation (IPPV) during the resuscitation of neonates at birth, to facilitate the early development of an effective functional residual capacity, reduce atelectotrauma and improve oxygenation after the birth of preterm infants. OBJECTIVE: The primary aim was to review the available literature on the use of SI compared with IPPV at birth in preterm infants for major neonatal outcomes, including bronchopulmonary dysplasia (BPD) and death. DATA SOURCE: MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials, until 6 October 2014. STUDY SELECTION: Randomised clinical trials comparing the effects of SI with IPPV at birth in preterm infants for neonatal outcomes. DATA EXTRACTION AND SYNTHESIS: Descriptive and quantitative information was extracted; data were pooled using a random effects model. Heterogeneity was assessed using the Q statistic and I(2). RESULTS: Pooled analysis showed significant reduction in the need for mechanical ventilation within 72 h after birth (relative risk (RR) 0.87 (0.77 to 0.97), absolute risk reduction (ARR) -0.10 (-0.17 to -0.03), number needed to treat 10) in preterm infants treated with an initial SI compared with IPPV. However, significantly more infants treated with SI received treatment for patent ductus arteriosus (RR 1.27 (1.05 to 1.54), ARR 0.10 (0.03 to 0.16), number needed to harm 10). There were no differences in BPD, death at the latest follow-up and the combined outcome of death or BPD among survivors between the groups. CONCLUSIONS: Compared with IPPV, preterm infants initially treated with SI at birth required less mechanical ventilation with no improvement in the rate of BPD and/or death. The use of SI should be restricted to randomised trials until future studies demonstrate the efficacy and safety of this lung aeration manoeuvre. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
CONTEXT: Sustained inflation (SI) has been advocated as an alternative to intermittent positive pressure ventilation (IPPV) during the resuscitation of neonates at birth, to facilitate the early development of an effective functional residual capacity, reduce atelectotrauma and improve oxygenation after the birth of preterm infants. OBJECTIVE: The primary aim was to review the available literature on the use of SI compared with IPPV at birth in preterm infants for major neonatal outcomes, including bronchopulmonary dysplasia (BPD) and death. DATA SOURCE: MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials, until 6 October 2014. STUDY SELECTION: Randomised clinical trials comparing the effects of SI with IPPV at birth in preterm infants for neonatal outcomes. DATA EXTRACTION AND SYNTHESIS: Descriptive and quantitative information was extracted; data were pooled using a random effects model. Heterogeneity was assessed using the Q statistic and I(2). RESULTS: Pooled analysis showed significant reduction in the need for mechanical ventilation within 72 h after birth (relative risk (RR) 0.87 (0.77 to 0.97), absolute risk reduction (ARR) -0.10 (-0.17 to -0.03), number needed to treat 10) in preterm infants treated with an initial SI compared with IPPV. However, significantly more infants treated with SI received treatment for patent ductus arteriosus (RR 1.27 (1.05 to 1.54), ARR 0.10 (0.03 to 0.16), number needed to harm 10). There were no differences in BPD, death at the latest follow-up and the combined outcome of death or BPD among survivors between the groups. CONCLUSIONS: Compared with IPPV, preterm infants initially treated with SI at birth required less mechanical ventilation with no improvement in the rate of BPD and/or death. The use of SI should be restricted to randomised trials until future studies demonstrate the efficacy and safety of this lung aeration manoeuvre. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Karen E McCall; Andreas D Waldmann; Prue Pereira-Fantini; Regina Oakley; Martijn Miedema; Elizabeth J Perkins; Peter G Davis; Peter A Dargaville; Stephan H Böhm; Raffaele Dellacà; Magdy Sourial; Emanuela Zannin; Anushi E Rajapaksa; Andre Tan; Andy Adler; Inéz Frerichs; David G Tingay Journal: Pediatr Res Date: 2017-07-12 Impact factor: 3.756
Authors: David G Tingay; Anushi Rajapaksa; Karen McCall; Cornelis E E Zonneveld; Don Black; Elizabeth Perkins; Magdy Sourial; Anna Lavizzari; Peter G Davis Journal: Pediatr Res Date: 2016-02-11 Impact factor: 3.756
Authors: Haresh Kirpalani; Sarah J Ratcliffe; Martin Keszler; Peter G Davis; Elizabeth E Foglia; Arjan Te Pas; Melissa Fernando; Aasma Chaudhary; Russell Localio; Anton H van Kaam; Wes Onland; Louise S Owen; Georg M Schmölzer; Anup Katheria; Helmut Hummler; Gianluca Lista; Soraya Abbasi; Daniel Klotz; Burkhard Simma; Vinay Nadkarni; Francis R Poulain; Steven M Donn; Han-Suk Kim; Won Soon Park; Claudia Cadet; Juin Yee Kong; Alexandra Smith; Ursula Guillen; Helen G Liley; Andrew O Hopper; Masanori Tamura Journal: JAMA Date: 2019-03-26 Impact factor: 56.272